CS logo
small CS logo
Neuroscience Research Australia

Randwick, New South Wales, Australia
Research foundation in Randwick, New South Wales
139 Barker St, Randwick NSW 2031

About Neuroscience Research Australia


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Neuroscience Research Australia


During the past decade, Neuroscience Research Australia conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Neuroscience Research Australia" #1 collaborator was "National Institute on Aging (NIA)" with 5 trials as a collaborator, "Alzheimer's Association" with 4 trials as a collaborator, "Accelerating Medicines Partnership (AMP)" with 3 trials as a collaborator, "Hoffmann-La Roche" with 3 trials as a collaborator and "Avid Radiopharmaceuticals" with 2 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 14 trials.

Clinical Trials Conditions at Neuroscience Research Australia


According to Clinical.Site data, the most researched conditions in "Neuroscience Research Australia" are "Alzheimers Disease" (4 trials), "Alzheimers Disease, Familial" (4 trials), "Dementia" (4 trials), "Alzheimer's Disease" (1 trials) and "Behavioral Variant Frontotemporal Dementia (bvFTD)" (1 trials). Many other conditions were trialed in "Neuroscience Research Australia" in a lesser frequency.

Clinical Trials Intervention Types at Neuroscience Research Australia


Most popular intervention types in "Neuroscience Research Australia" are "Drug" (5 trials), "Other" (3 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Gantenerumab" (3 trials), "Matching Placebo (Gantenerumab)" (3 trials), "E2814" (2 trials), "Lecanemab" (2 trials) and "Matching Placebo (E2814)" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Neuroscience Research Australia


The vast majority of trials in "Neuroscience Research Australia" are 9 trials for "All" genders.

Clinical Trials Status at Neuroscience Research Australia


Currently, there are NaN active trials in "Neuroscience Research Australia". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Neuroscience Research Australia, 1 suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Neuroscience Research Australia, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".